| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/06/2006 | WO2006029838A3 Secreted polypeptide species involved in alzheimer’s disease |
| 07/06/2006 | WO2006009888A3 C-met kinase binding proteins |
| 07/06/2006 | WO2005123916A3 Glycosylation-disrupted factor vii variants |
| 07/06/2006 | WO2005123111A3 Maxs as modifiers of the axin pathway and methods of use |
| 07/06/2006 | WO2005118626A3 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 07/06/2006 | WO2005117942A3 Methods for encapsulation of biomacromolecules in polymers |
| 07/06/2006 | WO2005115431A3 Methods for inhibiting proteasome and heat shock protein 90 |
| 07/06/2006 | WO2005110462A3 Methods and compositions for treatment of preeclampsia |
| 07/06/2006 | WO2005105129A3 Epitopes related to coeliac disease |
| 07/06/2006 | WO2005079419A3 Methods of treating immunopathological disorders |
| 07/06/2006 | WO2005077400A8 Cysteine rich peptides for improving thiol homeostasis |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2005010022A3 Agonist polypeptide of receptor for zot and zonulin |
| 07/06/2006 | WO2005001064A3 Polypeptides having alpha-amylase activity and polypeptides encoding same |
| 07/06/2006 | WO2004112565A3 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis |
| 07/06/2006 | WO2004100878A3 Method of treatment of hemorrhagic disease using a factor viia/tissue factor inhibitor |
| 07/06/2006 | WO2004072096A3 Peptides binding gp120 of hiv-1 |
| 07/06/2006 | WO2004062603A3 Methods of treating lung diseases |
| 07/06/2006 | WO2004061079A3 Candida kefyr cytosine deaminase |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | WO2004013157A3 REDUCING NgR-p75 MEDIATED BY INHIBITION OF AXON REGENERATION |
| 07/06/2006 | WO2003080797A3 6 human secreted proteins |
| 07/06/2006 | WO2003066829A3 Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof |
| 07/06/2006 | US20060150271 Artificial chromosomes, uses thereof and method for preparing artificial chromosomes |
| 07/06/2006 | US20060150267 Methods of using testis-specific insulin homolog polypeptides |
| 07/06/2006 | US20060150264 Differential gene expression in schizophrenia |
| 07/06/2006 | US20060150262 Novel mucin-like polypeptides |
| 07/06/2006 | US20060149050 Isolation and method of using tissue growth-inducing Frzb |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149040 Collagen and method for producing same |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060149034 Homing peptides to receptors of heart vasculature |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060149032 Recombinant hepatitis B surface antigen |
| 07/06/2006 | US20060148761 Lipids |
| 07/06/2006 | US20060148745 DNA-based aptamers for human cathepsin G |
| 07/06/2006 | US20060148735 Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors |
| 07/06/2006 | US20060148720 Use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus |
| 07/06/2006 | US20060148719 Antitumor agents promoting the production of GM progenitors in bone marrow cells, stimulating the cell differentiation, modulating hematopoiesis in bone marrow; L- gamma -glutamyl-3-[(phenylmethyl)sulfonyl]-L-alanyl-D-phenylglycine |
| 07/06/2006 | US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia |
| 07/06/2006 | US20060148717 Biocidal proteins |
| 07/06/2006 | US20060148716 Octapeptides: Arg-X-Asp-Leu-Asp-Ser-Leu-Arg where X is a 2-aminoaulfonylaminoalkanoic acid and optionally having various end groups; biologically active as ligands of blood platelet integrin GPIIbIIIa and the alpha v integrins |
| 07/06/2006 | US20060148715 Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands |
| 07/06/2006 | US20060148714 Therapeutic peptide-based constructs |
| 07/06/2006 | US20060148713 Use of exendins and agonists thereof for the reduction of food intake |
| 07/06/2006 | US20060148712 Monocyte chemoattractant activity of galectin-3 |
| 07/06/2006 | US20060148711 Molecular interactions in neurons |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148708 C5a receptor |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148706 Composition for wound healing and use thereof |
| 07/06/2006 | US20060148705 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 07/06/2006 | US20060148704 Supplemented matrices for the repair of bone fractures |
| 07/06/2006 | US20060148703 Sustained delivery of PDGF using self-assembling peptide nanofibers |
| 07/06/2006 | US20060148702 Protein kinase C inhibitors; for treatment of an ischemic event, reperfusion injury, vasoconstriction, vasospasm, stroke, or chronic high blood pressure |
| 07/06/2006 | US20060148701 Methyl or 2-propyl ester; acute respiratory distress syndrome, pneumonia, bronchitis, meconim aspiration syndrome, cystic fibrosis |
| 07/06/2006 | US20060148699 Counterion exchange process for peptides |
| 07/06/2006 | US20060148698 Storage-stable fibrinogen solutions |
| 07/06/2006 | US20060148697 Administering physiological agent that decreases or regulates blood or tissue levels, expression, production, function, or activity of luteinizing hormone (LH), LH receptors, follicle stimulating hormone (FSH), FSH receptor, androgenic steroid, androgenicsteroid receptors, an activin, activin receptor |
| 07/06/2006 | US20060148696 Contacting macrophage or T-cell with an effective amount of a cyclophilin from Toxoplasma or biologically active fragment thereof to inhibit HIV (human immunodeficiency virus) infection of a cell; kit with instructions |
| 07/06/2006 | US20060148695 Novel angiogenic composition and use thereof |
| 07/06/2006 | US20060148694 Inhibition of stress-induced ligand-dependent egfr activation |
| 07/06/2006 | US20060148693 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148691 Sustained release preparation for therapy of coronary stenosis or obstruction |
| 07/06/2006 | US20060148690 Secreted peptides |
| 07/06/2006 | US20060148689 A peptide consisting of a sequence comprising a tripeptide and tetrapeptide linked or existing separately with specific recognition of lipid vectors, particularly negativelycharged phosphatides on cell surfaces; stability; labels;fluorescence; imaging contrast agents; kitsanalyzing; diagnosis/medical |
| 07/06/2006 | US20060148688 Use of na, k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 07/06/2006 | US20060148687 Proteolysis resistant active vegf |
| 07/06/2006 | US20060148686 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 07/06/2006 | US20060148685 Use of substances with oxytocin activity against climacteric disorders |
| 07/06/2006 | US20060148684 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 07/06/2006 | US20060148683 Detection and treatment of intravascular lesions |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148681 Method for treating tumor and/or preventing tumor metastasis and relapse |
| 07/06/2006 | US20060148680 Glycoproteins produced in plants and methods of their use |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 07/06/2006 | US20060148678 Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products |
| 07/06/2006 | US20060148677 Chondrogenesis stimulator |
| 07/06/2006 | US20060148676 Polyamino acid-based particle insulin formulation |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060148674 Therapeutic composition |
| 07/06/2006 | US20060148086 Vault and vault-like carrier molecules |
| 07/06/2006 | US20060148084 Effect of growth hormone and IGF-1 on neural stem cells |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148073 Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product |
| 07/06/2006 | US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 07/06/2006 | US20060148057 Thioredoxin mutants and uses thereof |
| 07/06/2006 | US20060148055 Oxidised fragments of apolioprotein B and their uses |
| 07/06/2006 | US20060148038 Thrombin cleavable factor x analogues |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060148032 Novel phosphoprotein |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148020 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060148014 Tubulin isotype screening in cancer therapy using hemiasterlin analogs |
| 07/06/2006 | US20060148013 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060148002 Methods and compositions for the treatment and diagnosis of body weight disorders |